Argitalpenak (17) RAMÓN PATIÑO BARRIOS argitalpenak

2012

  1. Incipient renal impairment as a predictor of subclinical atherosclerosis in HIV-infected patients

    Journal of Acquired Immune Deficiency Syndromes, Vol. 59, Núm. 2, pp. 141-148

2006

  1. Autoantibodies against C-reactive protein: Clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome

    Journal of Rheumatology, Vol. 33, Núm. 10, pp. 1980-1986

2002

  1. Atorvastatin reduces expression of the CCR2 and MAC-1 receptors on monocytes, and plasma levels of monocyte chemoattractant protein-1 and C-reactive protein, in patients with coronary heart disease

    Clinical Drug Investigation, Vol. 22, Núm. 1, pp. 1-8

2000

  1. Circulating monocytes in patients with diabetes mellitus, arterial disease, and increased CD14 expression

    American Journal of Cardiology, Vol. 85, Núm. 11, pp. 1288-1291

1996

  1. Increased serum levels of IgA antibodies to hsp70 protein in patients with diabetes mellitus: Their relationship with vascular complications

    Clinical Immunology and Immunopathology, Vol. 79, Núm. 3, pp. 252-255

1994

  1. Increased plasma endothelin in diabetes: an atherosclerosis marker?

    Diabetologia

1993

  1. Plasma C3d levels and ischemic heart disease in type II diabetes

    Diabetes Care, Vol. 16, Núm. 2, pp. 445-449

1989

  1. Chemiluminescent immunoassay (CLIA) for urinary albumin.

    Journal of bioluminescence and chemiluminescence, Vol. 3, Núm. 4, pp. 169-174

1980

  1. Fibrinogen/fibrin degradation products in the diagnosis of pulmonary embolism in critically ill patients.

    Critical care medicine, Vol. 8, Núm. 11, pp. 646-650

  2. The role of growth hormone in the pathogenesis of postmenopausal osteoporosis

    Obstetrical and Gynecological Survey, Vol. 35, Núm. 6, pp. 369-371

1979

  1. Indomethacin effect on diuretic treated essential hypertension

    IRCS Medical Science, Vol. 7, Núm. 5, pp. 229

  2. The Role of Growth Hormone in the Pathogenesis of Postmenopausal Osteoporosis

    Archives of Internal Medicine, Vol. 139, Núm. 11, pp. 1263-1265

1976

  1. Concentración sérica del pdf. (productos de degradación de la fibrina) en el embolismo pulmonar agudo

    Revista Espanola de Cardiologia, Vol. 29, Núm. 1, pp. 3-8

  2. PRODUCTOS DE LA DEGRADACION DE LA FIBRINOLISIS EN EL EMBOLISMO PULMONAR EXPERIMENTAL. EFECTO DE LA HEPARINA SOBRE SU PRODUCCION

    Revista Espanola de Cardiologia, Vol. 29, Núm. 3, pp. 223-226

1974

  1. Diagnóstico de laboratorio del embolismo pulmonar

    Revista Espanola de Cardiologia, Vol. 27, Núm. 5, pp. 361-363

1973

  1. NEFRITIS INTERSTICIAL POR BRUCELLAS

    Revista Clinica Espanola, Vol. 129, Núm. 1, pp. 93-96

1972

  1. Efecto agudo del diazóxido en pacientes con hipertensión arterial maligna e insuficiencia renal.

    Revista Espanola de Cardiologia, Vol. 25, Núm. 2, pp. 147-154